TRACT Fundamental Analysis - TERACT SA

Fundamental Rating

Overall TRACT gets a fundamental rating of 2 out of 10. We evaluated TRACT against 57 industry peers in the Specialty Retail industry. Both the profitability and financial health of TRACT have multiple concerns. TRACT is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year TRACT has reported negative net income.

TRACT had a positive operating cash flow in the past year.

TRACT had negative earnings in 4 of the past 5 years.

TRACT had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

TRACT has a worse Return On Assets (-4.36%) than 73.68% of its industry peers.

The Return On Equity of TRACT (-21.64%) is worse than 70.18% of its industry peers.

		Industry Rank	Sector Rank
ROA	-4.36%
ROE	-21.64%
ROIC	N/A

ROA(3y)-6.32%

ROA(5y)-4.52%

ROE(3y)-27.09%

ROE(5y)-35.31%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TRACT has a better Gross Margin (43.35%) than 64.91% of its industry peers.

In the last couple of years the Gross Margin of TRACT has remained more or less at the same level.

TRACT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	43.35%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.67%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TRACT does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for TRACT remains at a similar level compared to 1 year ago.

Compared to 5 years ago, TRACT has more shares outstanding

TRACT has a better debt/assets ratio than last year.

2.2 Solvency

The Debt to FCF ratio of TRACT is 20.37, which is on the high side as it means it would take TRACT, 20.37 years of fcf income to pay off all of its debts.

Looking at the Debt to FCF ratio, with a value of 20.37, TRACT is in line with its industry, outperforming 40.35% of the companies in the same industry.

TRACT has a Debt/Equity ratio of 1.75. This is a high value indicating a heavy dependency on external financing.

TRACT's Debt to Equity ratio of 1.75 is on the low side compared to the rest of the industry. TRACT is outperformed by 78.95% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.75
Debt/FCF	20.37
Altman-Z	N/A

ROIC/WACCN/A

WACC5.01%

2.3 Liquidity

A Current Ratio of 0.90 indicates that TRACT may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.90, TRACT is doing worse than 78.95% of the companies in the same industry.

A Quick Ratio of 0.60 indicates that TRACT may have some problems paying its short term obligations.

TRACT's Quick ratio of 0.60 is in line compared to the rest of the industry. TRACT outperforms 57.89% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.9
Quick Ratio	0.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

TRACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.50%, which is quite impressive.

TRACT shows a decrease in Revenue. In the last year, the revenue decreased by -1.79%.

TRACT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.32% yearly.

EPS 1Y (TTM)26.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%1.96%

Revenue 1Y (TTM)-1.79%

Revenue growth 3Y11.32%

Revenue growth 5YN/A

Sales Q2Q%-0.3%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

TRACT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as TRACT.

TRACT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TRACT is cheaper than 91.23% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	2.56
EV/EBITDA	9.03

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

TRACT does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

TERACT SA

EPA:TRACT (11/28/2025, 7:00:00 PM)

0.95

+0 (+0.21%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners1.63%

Inst Owner ChangeN/A

Ins Owners12.67%

Ins Owner ChangeN/A

Market Cap66.47M

Revenue(TTM)895.20M

Net Income(TTM)-47.90M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.07
P/FCF	2.56
P/OCF	0.9
P/B	0.3
P/tB	N/A
EV/EBITDA	9.03

EPS(TTM)-0.69

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.37

FCFY39.11%

OCF(TTM)1.05

OCFY111.03%

SpS12.79

BVpS3.16

TBVpS-2.58

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-4.36%
ROE	-21.64%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	43.35%
FCFM	2.9%

ROA(3y)-6.32%

ROA(5y)-4.52%

ROE(3y)-27.09%

ROE(5y)-35.31%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.67%

GM growth 5YN/A

F-Score5

Asset Turnover0.82

Health

		Industry Rank	Sector Rank
Debt/Equity	1.75
Debt/FCF	20.37
Debt/EBITDA	5.99
Cap/Depr	56.17%
Cap/Sales	5.34%
Interest Coverage	N/A
Cash Conversion	114.07%
Profit Quality	N/A
Current Ratio	0.9
Quick Ratio	0.6
Altman-Z	N/A

F-Score5

WACC5.01%

ROIC/WACCN/A

Cap/Depr(3y)48.62%

Cap/Depr(5y)N/A

Cap/Sales(3y)4.05%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)26.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%1.96%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-1.79%

Revenue growth 3Y11.32%

Revenue growth 5YN/A

Sales Q2Q%-0.3%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-43.66%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y1852.94%

FCF growth 3Y102.29%

FCF growth 5YN/A

OCF growth 1Y184.83%

OCF growth 3Y46.27%

OCF growth 5YN/A

TERACT SA / TRACT.PA FAQ

Can you provide the ChartMill fundamental rating for TERACT SA?

ChartMill assigns a fundamental rating of 2 / 10 to TRACT.PA.

What is the valuation status of TERACT SA (TRACT.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to TERACT SA (TRACT.PA). This can be considered as Overvalued.

What is the profitability of TRACT stock?

TERACT SA (TRACT.PA) has a profitability rating of 2 / 10.

How financially healthy is TERACT SA?

The financial health rating of TERACT SA (TRACT.PA) is 1 / 10.

TERACT SA (TRACT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

TERACT SA / TRACT.PA FAQ

Can you provide the ChartMill fundamental rating for TERACT SA?

What is the valuation status of TERACT SA (TRACT.PA) stock?

What is the profitability of TRACT stock?

How financially healthy is TERACT SA?